Arsanis' Series D Round

Arsanis raised a round of funding on April 26, 2017.

Arsanis is a clinical-stage company creating precision monoclonal antibodies for the prevention and treatment of serious bacterial infections not effectively controlled by currently available treatmen…

Articles about Arsanis' Series D Round: